Alternatives to Palladyne AI

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI and 3D vision solutions for industrial robots, enhancing automation in manufacturing and logistics.

AI-powered platform for designing, programming, and deploying robotic automation cells.

Modular autonomy software for agricultural machinery.

Open-source robot middleware and operating system to accelerate robot development and deployment.

Gencomhealth is developing an AI-powered platform to accelerate drug discovery and development.

Vivodyne is developing advanced AI models for drug discovery and development.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing oral small molecule medicines for immunological and chronic diseases.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

Revita Labs is developing a platform to accelerate drug discovery and development using AI.

AI-powered platform for antibody discovery and development to create new medicines.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.

AI-powered drug discovery platform for accelerated molecular design.

Global life sciences company providing diagnostic and biopharma laboratory services.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered spatial biology platform for precision medicine and drug development.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered research assistant for scientific literature review and data extraction.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

AI-powered platform that automates drug discovery through physical AI scientists and robotic experimentation.

Developing novel immunotherapies and diagnostics for cancer.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

AI-powered cloud quality management system for life sciences.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Biotechnology company focused on developing treatments for rare metabolic diseases.